The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer using a multi-marker panel and a machine-learning approach: Final results of the prospective multicenter PERMAD trial.
 
Hans A. Kestler
No Relationships to Disclose
 
Thomas Jens Ettrich
Consulting or Advisory Role - AstraZeneca; Bayer; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Incyte; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen
 
Alexander Stein
Consulting or Advisory Role - Amgen (Inst); AstraZeneca; Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Merck KGaA; MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Pierre Fabre (Inst); Roche; SERVIER (Inst); Taiho Oncology (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Merck KGaA; Seagen (Inst); Servier
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pierre Fabre (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH
 
Dirk Arnold
No Relationships to Disclose
 
Gerald W. Prager
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BMSi; Daiichi Sankyo Europe GmbH; Incyte; Lilly; Merck Serono; MSD; Pierre Fabre; Roche/Genentech; SERVIER
 
Stefan Kasper
Employment - University Hospital Essen (I)
Honoraria - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Incyte; Janssen-Cilag; Lilly; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Roche/Genentech; SERVIER
Travel, Accommodations, Expenses - Amgen; BMS; Lilly; Merck Serono; Pierre Fabre; Roche; Sanofi
Other Relationship - Amgen; Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Sanofi
 
Michael Niedermeier
No Relationships to Disclose
 
Lothar Müller
No Relationships to Disclose
 
Stefan Kubicka
No Relationships to Disclose
 
Alexander Koenig
No Relationships to Disclose
 
Petra Buechner-Steudel
No Relationships to Disclose
 
Andreas Berger
No Relationships to Disclose
 
Kai Wille
No Relationships to Disclose
 
Angelika Kestler
No Relationships to Disclose
 
Johann M. Kraus
No Relationships to Disclose
 
Silke Werle
No Relationships to Disclose
 
Lukas Perkhofer
No Relationships to Disclose
 
Ludwig Lausser
No Relationships to Disclose
 
Thomas Seufferlein
No Relationships to Disclose